Terazocin Hydrochloride is a potent and selective α1-adrenergic receptor that may induce decreased blood pressure and is used in the treatment of benign prostatic hyperplasia. References: An GH, Kim MJ, Lee HJ, Park SS, Cho YW, Park K, Choa YH. Fabrication of terazocin-loaded poly(D,L-lactide) microspheres by an ultrasonic spray drying method and their release behaviors. J Nanosci Nanotechnol. 2008 Oct;8(10):5139-42. PubMed PMID: 19198407.

纯度：≥98%

CAS：63074-08-8